Conversations With Coleman
Psychedelic Medicine with Jeannie Fontana
Jul 14, 2023
Jeannie Fontana, CEO of the TREAT California Initiative, talks about the potential of psychedelic research in treating mental illness and improving well-being. She also discusses her advocacy work for ALS patients and stem cell research funding. The podcast explores the impact of politicizing science and reflections on COVID-19, politics, and mental health. It delves into barriers and streamlining research on stem cells and perspectives on psychedelic medicine. The speaker discusses traditional societies vs. the American approach to psychedelics and the importance of integrating Western medicine and Eastern philosophies for mental health.
01:06:14
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The TREAT California Initiative aims to create a $5 billion funding agency for psychedelic research in California, focusing on treating conditions like PTSD and depression.
- MDMA-assisted therapy has shown promise in treating PTSD, helping individuals open up, experience self-love, and heal from trauma.
Deep dives
The TREAT California Initiative
The TREAT California Initiative aims to create a $5 billion funding agency for psychedelic research in California. The initiative focuses on using psychedelics for the treatment of conditions like PTSD and depression. The goal is to collect one million voter signatures in California to put the TREAT Initiative on the 2024 ballot. The initiative seeks to bridge Western medicine and Eastern philosophies to create a new narrative around mental health and well-being. The ultimate aim is to make these therapies accessible, cost-effective, and safe for all.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
